
Porosome Therapeutics
Based in Boston, Porosome Therapeutics is a biotech firm offering membrane tech for disease treatment.
- 50
- Private company
Porosome Therapeutics, based in Boston, Massachusetts, is a biotech company focused on revolutionizing modern medicine through its membrane technology platform. The company's core mission is to leverage the discovery of the 'porosome,' the cell's secretory apparatus, to develop new treatments for diseases such as cystic fibrosis, diabetes, neurological disorders, immune disorders, and various cancers. By isolating and reconstituting the porosome into live cells, Porosome Therapeutics aims to address secretory defects that underlie many of these conditions.
The discovery and functional reconstitution of the porosome have positioned Porosome Therapeutics at the forefront of drug development and therapy innovation. This breakthrough has significant implications for treating a wide range of diseases, potentially transforming therapeutic approaches and improving patient outcomes. The company's pioneering work in this area underscores its impact on the biotech industry and its potential to bring about substantial advancements in medical science.
Similar Companies

Secretome Therapeutics

Permeon Biologics
permeonbio.com
Promosome
Bilayer Therapeutics
Peroxitech Therapeutics

ProFound Therapeutics
profoundtx.com

Mitosense
mitosenseinc.com

Moma Therapeutics
momatx.com

PAQ Therapeutics
paqtx.com

HemoShear Therapeutics
hemoshear.com

Jupiter Therapeutics
jupitertx.com

Mulberry Biotherapeutics
mulberrybio.com

Portal Biotechnologies
portal.bio

Bond Biosciences
bond.bio

Phoreus Biotechnology
phoreusbiotech.com
Neuropore Therapies
neuropore.com
Dome Therapeutics

Primrose Therapeutics

Poseida Therapeutics
poseida.com

Orpro Therapeutics
Quick Facts
Who are Porosome Therapeutics' competitors?
Companies similar to Porosome Therapeutics include Secretome Therapeutics, Permeon Biologics, Promosome and Bilayer Therapeutics.
When was Porosome Therapeutics founded?
Porosome Therapeutics was founded in 2021.
When was Porosome Therapeutics' last funding round?
Porosome Therapeutics' most recent funding round was for $1.5M (USD) in September 2023.
How much disclosed funding has Porosome Therapeutics raised?
As of Sep 14, 2023, Porosome Therapeutics has disclosed funding of $1.8M (USD). Undisclosed round amounts are excluded.
How many employees does Porosome Therapeutics have?
Porosome Therapeutics has 50 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Model
- Customer
- Main Product
- Also Known As
- Porosome Therapeutics, Inc
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified